Summary
Amgen Inc. (AMGN) filed an 8-K on October 28, 2015, to report its unaudited financial results for the third quarter and the first nine months of 2015, as well as its financial position as of September 30, 2015. The filing primarily serves to furnish a press release containing these results, which includes both GAAP and non-GAAP financial measures. Investors should note that this information is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act, meaning it doesn't carry the same legal liabilities as a formally filed report. The press release detailed the company's financial performance and condition, utilizing adjusted earnings per share, free cash flow, adjusted operating income, and other non-GAAP metrics. Amgen's management provided these non-GAAP figures to offer additional insights into the company's operational performance and financial health, which they believe are useful for investors. Reconciliations between GAAP and non-GAAP measures are available within the furnished press release.
Key Highlights
- 1Amgen Inc. reported its unaudited financial results for the three and nine months ended September 30, 2015.
- 2The filing includes a press release dated October 28, 2015, which contains the detailed financial information.
- 3Amgen utilized both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures in its reporting.
- 4Key non-GAAP metrics mentioned include adjusted earnings per share, free cash flow, and adjusted operating income.
- 5The company's management believes these non-GAAP measures provide useful information to investors.
- 6Reconciliations between GAAP and non-GAAP financial measures are provided within the press release.
- 7The information furnished in this 8-K is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.